Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.51 USD | -2.76% | -5.37% | -3.55% |
May. 13 | Recursion Pharmaceuticals Says BioHive-2 AI Supercomputer Completed | MT |
May. 10 | Recursion Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
Financials (USD)
Sales 2024 * | 58.86M | Sales 2025 * | 63.02M | Capitalization | 2.26B |
---|---|---|---|---|---|
Net income 2024 * | -401M | Net income 2025 * | -472M | EV / Sales 2024 * | 32.3 x |
Net cash position 2024 * | 358M | Net cash position 2025 * | 336M | EV / Sales 2025 * | 30.5 x |
P/E ratio 2024 * |
-5.79
x | P/E ratio 2025 * |
-5.22
x | Employees | 500 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.91% |
1 day | -2.76% | ||
1 week | -5.37% | ||
Current month | +21.61% | ||
1 month | +29.39% | ||
3 months | -23.12% | ||
6 months | +45.41% | ||
Current year | -3.55% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 41 | 13-11-04 | |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 20-03-19 |
Chairman | 60 | 20-03-31 | |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.51% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 9.51 | -2.76% | 3,026,433 |
24-05-20 | 9.78 | +3.82% | 3,494,664 |
24-05-17 | 9.42 | -0.95% | 4,735,549 |
24-05-16 | 9.51 | -5.00% | 4,872,789 |
24-05-15 | 10.01 | -0.40% | 6,873,234 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.55% | 2.26B | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-3.96% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- RXRX Stock